A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study

Abstract Coronavirus disease 2019 (COVID‐19) has spread worldwide. To date, no specific drug for COVID‐19 has been developed. Thus, this randomized, open‐label, controlled clinical trial (ChiCTR2000029853) was performed in China. A total of 20 mild and common COVID‐19 patients were enrolled and rand...

Full description

Bibliographic Details

Published in:	Advanced Science
Main Authors:	Zhigang Ren, Hong Luo, Zujiang Yu, Jingchao Song, Lan Liang, Ling Wang, Haiyu Wang, Guangying Cui, Yong Liu, Jin Wang, Qingquan Li, Zhaohai Zeng, Shengkun Yang, Guangzhong Pei, Yonghui Zhu, Wenbin Song, Wenquan Yu, Chuanjun Song, Lihong Dong, Chuansong Hu, Jinfa Du, Junbiao Chang
Format:	Article
Language:	English
Published:	Wiley 2020-10-01
Subjects:	azvudine COVID‐19 SARS‐CoV‐2
Online Access:	https://doi.org/10.1002/advs.202001435